Beverly E. Barton

2.0k total citations
50 papers, 1.6k citations indexed

About

Beverly E. Barton is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Beverly E. Barton has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 19 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in Beverly E. Barton's work include Cytokine Signaling Pathways and Interactions (17 papers), Immune Cell Function and Interaction (7 papers) and interferon and immune responses (6 papers). Beverly E. Barton is often cited by papers focused on Cytokine Signaling Pathways and Interactions (17 papers), Immune Cell Function and Interaction (7 papers) and interferon and immune responses (6 papers). Beverly E. Barton collaborates with scholars based in United States, United Kingdom and India. Beverly E. Barton's co-authors include James V. Jackson, Thomas F. Murphy, Andrew M. Rauth, Hosea F. S. Huang, Robert J. Mayer, Arnold B. Barton, M. Domon, A. L. Porte, James Jakway and Marvín I. Siegel and has published in prestigious journals such as The Journal of Immunology, Infection and Immunity and Virology.

In The Last Decade

Beverly E. Barton

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly E. Barton United States 22 604 449 418 223 206 50 1.6k
Nicola Kouttab United States 28 711 1.2× 415 0.9× 447 1.1× 107 0.5× 179 0.9× 67 2.1k
Sally L. D. MacKay United States 20 613 1.0× 267 0.6× 319 0.8× 327 1.5× 159 0.8× 25 1.5k
James H. Steer Australia 24 977 1.6× 623 1.4× 541 1.3× 444 2.0× 129 0.6× 45 2.4k
Roberto P. Meiss Argentina 24 697 1.2× 329 0.7× 321 0.8× 250 1.1× 86 0.4× 79 1.6k
R Neta United States 25 526 0.9× 444 1.0× 868 2.1× 181 0.8× 160 0.8× 44 2.2k
Vitam Kodelja Germany 18 518 0.9× 315 0.7× 770 1.8× 82 0.4× 180 0.9× 26 1.8k
Velmurugesan Arulampalam Sweden 22 1.0k 1.7× 226 0.5× 463 1.1× 188 0.8× 370 1.8× 32 1.8k
Kazuko Uno Japan 25 673 1.1× 348 0.8× 565 1.4× 98 0.4× 269 1.3× 100 2.2k
Thomas J. Connors United States 14 659 1.1× 331 0.7× 982 2.3× 109 0.5× 235 1.1× 33 2.1k
Shinobu Sakamoto Japan 20 540 0.9× 273 0.6× 208 0.5× 88 0.4× 160 0.8× 98 1.5k

Countries citing papers authored by Beverly E. Barton

Since Specialization
Citations

This map shows the geographic impact of Beverly E. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly E. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly E. Barton more than expected).

Fields of papers citing papers by Beverly E. Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly E. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly E. Barton. The network helps show where Beverly E. Barton may publish in the future.

Co-authorship network of co-authors of Beverly E. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly E. Barton. A scholar is included among the top collaborators of Beverly E. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly E. Barton. Beverly E. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Huw D., et al.. (2010). Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines. BMC Biotechnology. 10(1). 79–79. 17 indexed citations
2.
Itagaki, Kiyoshi, Beverly E. Barton, Thomas F. Murphy, et al.. (2009). Eicosanoid-Induced Store-Operated Calcium Entry in Dendritic Cells. Journal of Surgical Research. 169(2). 301–310. 16 indexed citations
3.
Tripathi, Snehlata, Binay Chaubey, Beverly E. Barton, & Virendra N. Pandey. (2007). Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome. Virology. 363(1). 91–103. 24 indexed citations
4.
Huang, Hosea F. S., Thomas F. Murphy, Ping Shu, Arnold B. Barton, & Beverly E. Barton. (2005). Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.. Molecular Cancer. 4(1). 2–2. 46 indexed citations
5.
Wang, Guichun, et al.. (2005). Impaired Sperm Function After Spinal Cord Injury in the Rat Is Associated With Altered Cyclic Adenosine Monophosphate Signaling. Journal of Andrology. 26(5). 592–600. 6 indexed citations
7.
Goldstein, Kenneth, et al.. (2002). Effects of hemispheric lateralization and site specificity on immune alterations induced by kindled temporal lobe seizures. Brain Behavior and Immunity. 16(6). 706–719. 20 indexed citations
8.
Barton, Beverly E. & Thomas F. Murphy. (2001). CANCER CACHEXIA IS MEDIATED IN PART BY THE INDUCTION OF IL-6-LIKE CYTOKINES FROM THE SPLEEN. Cytokine. 16(6). 251–257. 42 indexed citations
9.
Barton, Beverly E.. (2001). IL-6-Like Cytokines and Cancer Cachexia: Consequences of Chronic Inflammation. Immunologic Research. 23(1). 41–58. 81 indexed citations
10.
11.
Barton, Beverly E., et al.. (2000). A Model that Reproduces Syndromes Associated with Human Multiple Myeloma in Nonirradiated SCID Mice. Proceedings of The Society for Experimental Biology and Medicine. 223(2). 190–197. 13 indexed citations
12.
Barton, Beverly E. & Thomas F. Murphy. (2000). CONSTITUTIVE EXPRESSION OF IL-6-LIKE CYTOKINES IN NORMAL BONE MARROW: IMPLICATIONS FOR PATHOPHYSIOLOGY OF MYELOMA. Cytokine. 12(10). 1537–1545. 12 indexed citations
13.
Barton, Beverly E.. (1997). IL-6: Insights into Novel Biological Activities. Clinical Immunology and Immunopathology. 85(1). 16–20. 218 indexed citations
14.
Barton, Beverly E.. (1996). The biological effects of interleukin 6. Medicinal Research Reviews. 16(1). 87–109. 118 indexed citations
15.
Jadus, Martin R., et al.. (1995). The identification of the neonatal NBXFO hybridoma cell and its mediator. Developmental & Comparative Immunology. 19(3). 261–277. 5 indexed citations
16.
Barton, Beverly E., et al.. (1994). Oncostatin M stimulates proliferation in B9 hybridoma cells: Potential role of oncostatin M in plasmacytoma development. Cytokine. 6(2). 147–153. 12 indexed citations
17.
Barton, Beverly E., et al.. (1991). Cytokine Inhibition by A Novel Steroid, Mometasone Furoate. Immunopharmacology and Immunotoxicology. 13(3). 251–261. 63 indexed citations
18.
Barton, Beverly E., et al.. (1990). IL 3 and IL 6 do not induce bone resorption in vitro. Cytokine. 2(3). 217–220. 25 indexed citations
19.
Kirchhof, Bernd, et al.. (1989). Macrophage modulation of retinal pigment epithelial cell migration and proliferation. Graefe s Archive for Clinical and Experimental Ophthalmology. 227(1). 60–66. 34 indexed citations
20.
Barton, Beverly E., et al.. (1988). Relative Allergenic Potential of Four Proteases Used as Contact Lens Cleaners. Optometry and Vision Science. 65(2). 70–75. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026